AC Immune ACIU
NASDAQ ACIU
$2.49 +0.00 (+0.00%)
As of: Oct 21, 2026 · 1:16 PM EDT

AC Immune (ACIU) EV to EBITDA (2019)

Updated

AC Immune's EV to EBITDA came in at 10.45 for the quarter ended Dec 31, 2019, compared with 0.56 a year earlier.

Analysis

AC Immune (ACIU) EV to EBITDA (2019) Analysis & Trends

For the year ended Dec 31, 2019, AC Immune's EV to EBITDA was 6.98.

  • Going back by year, EV to EBITDA was 0.55 in the year ended Dec 31, 2018.
  • Business Quant data shows ACIU's EV to EBITDA at 0.03 (quarter ended Sep 30, 2019), 0.09 (quarter ended Jun 30, 2019) and 0.04 (quarter ended Mar 31, 2019) in the three quarters before the quarter ended Dec 31, 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,209.53 Bn 1,178.12 Bn 19.71 Bn
2 Johnson & Johnson 625.18 Bn 543.70 Bn 17.26 Bn
3 AbbVie 510.63 Bn 483.79 Bn 12.70 Bn
4 Merck 365.88 Bn 320.31 Bn 12.21 Bn
5 Novartis Ag 293.11 Bn 257.51 Bn 11.24 Bn
6 Astrazeneca 261.69 Bn 235.45 Bn 12.86 Bn
7 Amgen 237.29 Bn 192.69 Bn 7.24 Bn
8 Gilead Sciences 194.23 Bn 168.34 Bn 6.22 Bn
9 Pfizer 171.73 Bn 118.68 Bn 10.94 Bn
10 AC Immune 253.34 Mn -185.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 6.81
Sep 30, 2019 0.58
Jun 30, 2019 4.15
Mar 31, 2019 1.65
API Access

AC Immune EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ACIU&period=max&api_key=YOUR_API_KEY